# Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes

Study · id `cardio:ct-nct03194945` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03194945](<https://clinicaltrials.gov/study/NCT03194945>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03194945

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 412 participants.

## Technical summary

Registry record NCT03194945. Randomized; no masking; primary purpose treatment. Start 2017-11-01 (actual); primary completion 2022-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 412 participants (enrolled count; ClinicalTrials.gov record NCT03194945, source copy `cardio:ctgov-nct03194945-2024-06-18`, retrieved 2026-10-26)
- Started: 2017-11-01 (actual) (ClinicalTrials.gov record NCT03194945, source copy `cardio:ctgov-nct03194945-2024-06-18`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (actual) (ClinicalTrials.gov record NCT03194945, source copy `cardio:ctgov-nct03194945-2024-06-18`, retrieved 2026-10-26)
- Completion: 2022-12-31 (actual) (ClinicalTrials.gov record NCT03194945, source copy `cardio:ctgov-nct03194945-2024-06-18`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03194945, source copy `cardio:ctgov-nct03194945-2024-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03194945-2024-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): CSII followed by Lina+MET
- Intervention (Drug): CSII followed by Lina
- Intervention (Drug): CSII followed by MET
- Intervention (Drug): CSII alone
- Lead sponsor: Sun Yat-sen University
- Lead sponsor class: OTHER
- Collaborator: The Seventh Affiliated Hospital of Sun Yat-sen University
- Collaborator class: OTHER
- Collaborator: Guangdong Provincial Hospital of Traditional Chinese Medicine
- Collaborator class: OTHER
- Collaborator: Guangdong Provincial People's Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital with Nanjing Medical University
- Collaborator class: OTHER
- Collaborator: Dongguan People's Hospital
- Collaborator class: OTHER\_GOV
- Collaborator: Clifford Hospital
- Collaborator class: UNKNOWN
- Collaborator: Guangzhou Panyu Central Hospital
- Collaborator class: OTHER
- Collaborator: Nanfang Hospital, Southern Medical University
- Collaborator class: OTHER
- Collaborator: Chinese PLA General Hospital
- Collaborator class: OTHER
- Collaborator: Peking University People's Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai 10th People's Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai Changzheng Hospital
- Collaborator class: OTHER
- Collaborator: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Collaborator class: OTHER
- Collaborator: Huizhou Municipal Central Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial (`cardio:pubmed-39406449`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 12 registry organizations

## Provenance

Content hash: 4cf4482c8dfa13e7091136f76ca246f6ffd76e28d56be18a396ac76aed1696a9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
